BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25803180)

  • 1. Kalkitoxin inhibits angiogenesis, disrupts cellular hypoxic signaling, and blocks mitochondrial electron transport in tumor cells.
    Morgan JB; Liu Y; Coothankandaswamy V; Mahdi F; Jekabsons MB; Gerwick WH; Valeriote FA; Zhou YD; Nagle DG
    Mar Drugs; 2015 Mar; 13(3):1552-68. PubMed ID: 25803180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons.
    LePage KT; Goeger D; Yokokawa F; Asano T; Shioiri T; Gerwick WH; Murray TF
    Toxicol Lett; 2005 Aug; 158(2):133-9. PubMed ID: 16039402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The marine sponge metabolite mycothiazole: a novel prototype mitochondrial complex I inhibitor.
    Morgan JB; Mahdi F; Liu Y; Coothankandaswamy V; Jekabsons MB; Johnson TA; Sashidhara KV; Crews P; Nagle DG; Zhou YD
    Bioorg Med Chem; 2010 Aug; 18(16):5988-94. PubMed ID: 20637638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Caulerpa pigment caulerpin inhibits HIF-1 activation and mitochondrial respiration.
    Liu Y; Morgan JB; Coothankandaswamy V; Liu R; Jekabsons MB; Mahdi F; Nagle DG; Zhou YD
    J Nat Prod; 2009 Dec; 72(12):2104-9. PubMed ID: 19921787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis and biological evaluation of +-kalkitoxin, a cytotoxic metabolite of the cyanobacterium Lyngbya majuscula.
    White JD; Xu Q; Lee CS; Valeriote FA
    Org Biomol Chem; 2004 Jul; 2(14):2092-102. PubMed ID: 15254638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antillatoxin and kalkitoxin, ichthyotoxins from the tropical cyanobacterium Lyngbya majuscula, induce distinct temporal patterns of NMDA receptor-mediated neurotoxicity.
    Berman FW; Gerwick WH; Murray TF
    Toxicon; 1999 Nov; 37(11):1645-8. PubMed ID: 10482399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.
    Chen MC; Hsu WL; Hwang PA; Chou TC
    Mar Drugs; 2015 Jul; 13(7):4436-51. PubMed ID: 26193287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway.
    Kim A; Ma JY
    Int J Oncol; 2018 Sep; 53(3):1160-1170. PubMed ID: 30015877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laurenditerpenol, a new diterpene from the tropical marine alga Laurenciaintricata that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells.
    Mohammed KA; Hossain CF; Zhang L; Bruick RK; Zhou YD; Nagle DG
    J Nat Prod; 2004 Dec; 67(12):2002-7. PubMed ID: 15620241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
    Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
    Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response.
    Kruger EA; Blagosklonny MV; Dixon SC; Figg WD
    Invasion Metastasis; 1998-1999; 18(4):209-18. PubMed ID: 10640907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
    Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
    Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J; Kaushik S; Rath SK; Balapure AK
    Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
    Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells.
    Kim ES; Hong SY; Lee HK; Kim SW; An MJ; Kim TI; Lee KR; Kim WH; Cheon JH
    Oncol Rep; 2008 Dec; 20(6):1321-7. PubMed ID: 19020709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic hypoxic cytotoxin TX-402 inhibits hypoxia-inducible factor 1 signaling pathway.
    Nagasawa H; Mikamo N; Nakajima Y; Matsumoto H; Uto Y; Hori H
    Anticancer Res; 2003; 23(6a):4427-34. PubMed ID: 14666730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.